培美曲塞说明书-英文-FDA

培美曲塞说明书-英文-FDA

ID:37800697

大小:463.47 KB

页数:20页

时间:2019-05-31

培美曲塞说明书-英文-FDA_第1页
培美曲塞说明书-英文-FDA_第2页
培美曲塞说明书-英文-FDA_第3页
培美曲塞说明书-英文-FDA_第4页
培美曲塞说明书-英文-FDA_第5页
培美曲塞说明书-英文-FDA_第6页
培美曲塞说明书-英文-FDA_第7页
培美曲塞说明书-英文-FDA_第8页
培美曲塞说明书-英文-FDA_第9页
培美曲塞说明书-英文-FDA_第10页
资源描述:

《培美曲塞说明书-英文-FDA》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库

1、HIGHLIGHTSOFPRESCRIBINGINFORMATION-------------------------------CONTRAINDICATIONS------------------------------ThesehighlightsdonotincludealltheinformationneededtouseHistoryofseverehypersensitivityreactiontopemetrexed.(4)ALIMTAsafelyandeffectively.Seefullprescribing

2、informationfor------------------------WARNINGSANDPRECAUTIONS-----------------------ALIMTA.•Premedicationregimen:InstructpatientstotakefolicacidandALIMTA(pemetrexeddisodium)Injection,Powder,Lyophilized,ForvitaminB12.PretreatmentwithdexamethasoneorequivalentreducesSolu

3、tionforIntravenoususecutaneousreaction.(5.1)InitialU.S.Approval:2004•Bonemarrowsuppression:Reducedosesforsubsequentcyclesbasedonhematologicandnonhematologictoxicities.(5.2)---------------------------RECENTMAJORCHANGES--------------------------•Renalfunction:Donotadmi

4、nisterwhenCrCl<45mL/min.(2.4,5.3)IndicationsandUsage,Non-SmallCellLungCancer—Combinationwith•NSAIDswithrenalinsufficiency:UsecautioninpatientswithmildtoCisplatin(1.1)09/2008moderaterenalinsufficiency(CrCl45-79mL/min).(5.4)3•Labmonitoring:DonotbeginnextcycleunlessANCu

5、1500cells/mm,IndicationsandUsage,Non-SmallCellLungCancer—Single-Agent(1.2)3plateletsu100,000cells/mm,andCrClu45mL/min.(5.5)09/2008•Pregnancy:FetalharmcanoccurwhenadministeredtoapregnantDosageandAdministrationCombinationUsewithCisplatin(2.1)09/2008woman.Womenshouldbea

6、dvisedtouseeffectivecontraceptionmeasurestopreventpregnancyduringtreatmentwithALIMTA.(5.6)----------------------------INDICATIONSANDUSAGE---------------------------ALIMTA®isafolateanalogmetabolicinhibitorindicatedfor:-------------------------------ADVERSEREACTIONS---

7、---------------------------•NonsquamousNon-SmallCellLungCancer:initialtreatmentinThemostcommonadversereactions(incidenceu20%)withsingle-agentusecombinationwithcisplatin.(1.1)arefatigue,nausea,andanorexia.Additionalcommonadversereactionswhen•NonsquamousNon-SmallCellLu

8、ngCancerasasingle-agentafterpriorusedincombinationwithcisplatinincludevomiting,neutropenia,leukopenia,chemotherapy(1.2)anemia,stoma

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。